When text on street signs starts to blur or night driving feels harder than it used to, choosing a certified ophthalmologist in Cape Coral becomes less of ...
US News evaluated freestanding ASCs only, excluding hospital-affiliated outpatient departments to avoid overlap with hospital rankings and maintain comparability across facility types. Methodology ...
One medtech analyst raises concerns that Lensar's acquisition by Alcon is in trouble due to the company's recent priority ...
Alcon and Lensar terminate merger due to FTC challenges. Lensar retains a $10M deposit and focuses on Ally laser growth. More updates on March 31.
Most health insurance plans in India don’t automatically cover LASIK, but exceptions exist. Here’s how medical necessity, limits and waiting periods determine your eligibility.
Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that three scientific abstracts highlighting its commercial products VEVYE® ...
I testified on three Bills at the Colorado Assembly on March 9, 2026. For the third time in a decade, Legislative Democrats blocked a bill requiring safety regulations and inspections for second ...
Lensar today entered into a priority credit line agreement in a move that analysts say casts doubt over its planned acquisition by Alcon.
The medical landscape undergoes a rapid transformation as precision becomes the standard of care. At the heart of this ...
Anti-VEGF use for ROP is expanding beyond bevacizumab and ranibizumab, with aflibercept’s fusion-protein structure conferring systemic exposure characteristics distinct from antibody-based agents.
As Spring approaches and your thoughts begin to turn to those outdoor pleasures, it may be the right time to put your wellbeing first and get it sorted! For more information about Wellsoon private ...
Harrow, Inc. is rapidly evolving into a dominant US ophthalmic pharma player, with a 30-fold revenue increase since 2015 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results